Next Article in Journal
Accumulation of Stable Full-Length Circular Group I Intron RNAs during Heat-Shock
Next Article in Special Issue
Developing HIV-1 Protease Inhibitors through Stereospecific Reactions in Protein Crystals
Previous Article in Journal
The Effects of Pre-Fermentative Addition of Oenological Tannins on Wine Components and Sensorial Qualities of Red Wine
Previous Article in Special Issue
Novel Halogenated Pyrazine-Based Chalcones as Potential Antimicrobial Drugs
Article Menu
Issue 11 (November) cover image

Export Article

Open AccessReview
Molecules 2016, 21(11), 1448; doi:10.3390/molecules21111448

Discovery of Bioactive Compounds by the UIC-ICBG Drug Discovery Program in the 18 Years Since 1998

1
School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China
2
Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, IL 60612, USA
These authors contributed equally to this work.
*
Author to whom correspondence should be addressed.
Academic Editor: Josef Jampilek
Received: 30 September 2016 / Revised: 24 October 2016 / Accepted: 25 October 2016 / Published: 31 October 2016
View Full-Text   |   Download PDF [1472 KB, uploaded 31 October 2016]   |  

Abstract

The International Cooperative Biodiversity Groups (ICBG) Program based at the University of Illinois at Chicago (UIC) is a program aimed to address the interdependent issues of inventory and conservation of biodiversity, drug discovery and sustained economic growth in both developing and developed countries. It is an interdisciplinary program involving the extensive synergies and collaborative efforts of botanists, chemists and biologists in the countries of Vietnam, Laos and the USA. The UIC-ICBG drug discovery efforts over the past 18 years have resulted in the collection of a cumulative total of more than 5500 plant samples (representing more than 2000 species), that were evaluated for their potential biological effects against cancer, HIV, bird flu, tuberculosis and malaria. The bioassay-guided fractionation and separation of the bioactive plant leads resulted in the isolation of approximately 300 compounds of varying degrees of structural complexity and/or biological activity. The present paper summarizes the significant drug discovery achievements made by the UIC-ICBG team of multidisciplinary collaborators in the project over the period of 1998–2012 and the projects carried on in the subsequent years by involving the researchers in Hong Kong. View Full-Text
Keywords: UIC-ICBG; bioactive compounds; drug discovery; cancer; HIV; tuberculosis; malaria UIC-ICBG; bioactive compounds; drug discovery; cancer; HIV; tuberculosis; malaria
Figures

Figure 1a

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Zhang, H.-J.; Li, W.-F.; Fong, H.H.S.; Soejarto, D.D. Discovery of Bioactive Compounds by the UIC-ICBG Drug Discovery Program in the 18 Years Since 1998. Molecules 2016, 21, 1448.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top